Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell...
Dr Owen O'Connor - Columbia University Medical Centre, New York, USA
ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma ( Dr Owen O'Connor - Columbia University Medical Centre, New York, USA )
2 Dec 2018
Diversity of gut microbiota linked with complications from haematopoietic cell t...
Dr Jonathan Peled - Memorial Sloan Kettering Cancer Centre, New York, USA
Diversity of gut microbiota linked with complications from haematopoietic cell transplantation ( Dr Jonathan Peled -  Memorial Sloan Kettering Cancer Centre, New York, USA )
2 Dec 2018
Ibrutinib alone and in combination with rituximab for older patients with chroni...
Dr Jennifer Woyach - The Ohio State University Comprehensive Cancer Centre, Colu...
Ibrutinib alone and in combination with rituximab for older patients with chronic lymphocytic leukaemia ( Dr Jennifer Woyach - The Ohio State University Comprehensive Cancer Centre, Columbus, USA )
1 Dec 2018
Latest analysis of the ELIANA trial for acute lymphocytic leukaemia
Dr Stephan Grupp - University of Pennsylvania, Philadelphia, USA
Latest analysis of the ELIANA trial for acute lymphocytic leukaemia ( Dr Stephan Grupp - University of Pennsylvania, Philadelphia, USA )
1 Dec 2018
Stem cell transplant after CAR T-cell therapy reduces relapses in acute lymphocy...
Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA
Stem cell transplant after CAR T-cell therapy reduces relapses in acute lymphocytic leukaemia ( Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA )
1 Dec 2018
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
Dr Maria Domenica Cappellini - University of Milan, Milan, Italy
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS ( Dr Maria Domenica Cappellini - University of Milan, Milan, Italy )
1 Dec 2018
For HSCT in Ph-positive ALL
Prof Oliver Ottmann - Cardiff University, Cardiff, UK
For HSCT in Ph-positive ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )
18 Oct 2018
Transplanting adult ALL patients
Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw...
Transplanting adult ALL patients ( Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland )
18 Oct 2018
Management of MLL-rearranged ALL
Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht,...
Management of MLL-rearranged ALL ( Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands )
18 Oct 2018
Against HSCT in Ph-positive ALL
Prof Robin Foa - Professor of Haematology and Head of Haematology, University of...
Against HSCT in Ph-positive ALL ( Prof Robin Foa - Professor of Haematology and Head of Haematology, University of Rome, Rome, Italy )
18 Oct 2018
Large B-cell lymphoma: ZUMA-1 trial
Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA
Large B-cell lymphoma: ZUMA-1 trial ( Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA )
7 Aug 2018
Treating myelodysplastic syndromes
Prof Hugo Fernandez - Moffitt Cancer Center, Tampa, USA
Treating myelodysplastic syndromes ( Prof Hugo Fernandez - Moffitt Cancer Center, Tampa, USA )
7 Aug 2018